Skip to main content
SLNSilence Therapeutics Plc - AmerSell6.6·$10.13
SLN · Decision

Should you buy Silence Therapeutics Plc - Amer (SLN)?

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Verdict
SELL
Score
6.6/10
Price
$10.13
Entry / Take Profit (TP) / Stop Loss (SL)
/ $25.38 / $9.66

Engine methodology range

Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.

What the engine is tracking

  • Extreme Cash Burn Rule Of 40 FailStable
  • Explosive Revenue GrowthStable
  • Overbought Momentum Asymmetric UpsideStable
  • +2 more pillars — see the Why tab for full reasoning

→ Full pillar scorecard with all 5 pillars + per-dimension breakdown

When this thesis breaks

Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Explosive Revenue Growth

    Trip ifRevenue growth falls below 50% YoY for 2 consecutive quarters.

  • P2Extreme Cash Burn Rule Of 40 Fail

    Trip ifFree cash flow margin rises above -500% of revenue for 2 consecutive quarters.

  • P3Overbought Momentum Asymmetric Upside

    Trip ifPrice falls below the $9.66 stop-loss level, invalidating the 9.62x asymmetry setup.

  • P4Elevated Options Hedging Activity

    Trip ifPut/call ratio falls below 1.0, reversing the current elevated hedging posture.

  • P5Volatile Earnings Track Record

    Trip ifThe company beats EPS estimates in at least 3 of the next 4 quarters, improving on the current 2-of-4 beat rate.

How the engine reached this verdict

1. Direct answer

TrendMatrix's engine output for Silence Therapeutics Plc - Amer (SLN) is SELL_IF_HOLDING with medium conviction, score 6.6/10 at $10.13. An L1 hard-floor gate blocked the positive-verdict path — Quality below minimum threshold; dimensional pillars cannot lift the engine output above the verdict floor while the L1 gate is active.

2. What would change the verdict

SELL output reflects multiple gate failures; recovery requires a confluence of those gates re-clearing, not a single dimension move.

3. What the engine sees

On the bear side: Quality below floor (3.5 < 4.0). Active engine warnings: Quality below floor (3.5 < 4.0).

4. Entry, target, and stop

The engine's exit framework anchors to a tactical sell band near $10.13, with structural invalidation at $9.66. The asymmetric R:R against a reversal hypothesis is 9.62 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).

For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates SLN — 10-dimension breakdown →

Bear case

  • Quality below floor (3.5 < 4.0)
Home Stocks SLN Buy or sell?